reports
Philip Morris International to Present at 2024 Jefferies Virtual Reduc...
STAMFORD, CT--(BUSINESS WIRE)-- Regulatory News: Philip Morris International Inc. (PMI) (NYSE: PM) will present at the 2024 Jefferies Virtual Reduced Risk Seminar on May 7, 2024. “The Science of Smoke-Free Products & Nicotine” will be presented by Gizelle Baker, VP Global Scientific Engagement, at 09:00 a.m. ET. “Leading & Transforming Through Innovation in Smoke-Free Products” will be presented by Stefano Volpetti, President Smoke-Free Inhalable Products & Chief Consumer Officer, at 11:00 a.m. ET. The webcast of the presentations will be available at . The slides and archived recordings...
Philip Morris International to Host Webcast of 2024 Virtual Annual Mee...
STAMFORD, CT--(BUSINESS WIRE)-- Regulatory News: Philip Morris International Inc. (PMI) (NYSE: PM) will host a live audio webcast of its 2024 Annual Meeting of Shareholders on Wednesday, May 8, 2024, at 9:00 a.m. ET. The meeting will be held in a virtual format only and can be accessed at . Presentation slides, script and an archived recording of the webcast will be available at the same link. The recording will be available for approximately one year from the date of the meeting. During the meeting, André Calantzopoulos, Executive Chairman of the Board, and Jacek Olczak, Chief Executive O...
Myriad Genetics to Release First Quarter 2024 Financial Results on May...
Myriad Genetics to Release First Quarter 2024 Financial Results on May 7, 2024 Management will also participate in four upcoming investor healthcare conferences SALT LAKE CITY, April 30, 2024 (GLOBE NEWSWIRE) -- . (NASDAQ: MYGN), a leader in genetic testing and precision medicine, will hold its first quarter earnings conference call on Tuesday, May 7, 2024 at 4:30pm ET. The company’s quarterly earnings will be released the same day after the market closes. During the call, Myriad management will provide a financial overview and business update of the company’s performance for the first...
Philip Morris International Inc: 1 director
A director at Philip Morris International Inc sold 20,000 shares at 96.420USD and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last t...
BlackLine Announces Date for First Quarter 2024 Earnings Release and C...
BlackLine Announces Date for First Quarter 2024 Earnings Release and Conference Call LOS ANGELES, April 23, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: BL) announced today that it will release financial results for the first quarter ended March 31, 2024 after market close on Tuesday, May 7, 2024 followed by a conference call hosted by management at 2:00 p.m. PT / 5:00 p.m. ET. A live webcast and replay will be accessible on BlackLine’s investor relations website at . To access the conference call by phone, please register , and dial-in details will be provided. To avoid delays, we encourage partic...
Philip Morris International Reports First-Quarter 2024 Results and Upd...
STAMFORD, CT--(BUSINESS WIRE)-- Regulatory News: Philip Morris International Inc. (PMI) (NYSE: PM) today announces its 2024 first-quarter results1. "The strength of our first-quarter results with excellent top-line growth and significant margin expansion gives us the confidence to raise our 2024 currency-neutral guidance,” said Jacek Olczak, Chief Executive Officer. "Strong smoke-free momentum continues with rapid underlying volume progression and accelerating organic net revenue and gross profit growth, fueled by the operating leverage of IQOS and the best-in-class economics of ZYN.” ...
Nearly Half of Americans Say They’ve Lost Time in Their Lives Due to P...
Nearly Half of Americans Say They’ve Lost Time in Their Lives Due to Poor Mental Health, According to the GeneSight Mental Health Monitor 80% of people diagnosed with anxiety, depression report losing years or decades of time SALT LAKE CITY, April 17, 2024 (GLOBE NEWSWIRE) -- An astonishing 44% of Americans feel they have lost time in their lives due to poor mental health. That number jumps to nearly 80% for those diagnosed with anxiety and/or depression, according to the latest Mental Health Monitor, a nationwide survey from , Inc. (NASDAQ:MYGN), a leader in genetic testing and precis...
Philip Morris International to Host Webcast of 2024 First-Quarter Resu...
STAMFORD, CT--(BUSINESS WIRE)-- Regulatory News: Philip Morris International Inc. (PMI) (NYSE: PM) will host a live audio webcast at on Tuesday, April 23, 2024, at 9:00 a.m. ET, to discuss its 2024 first-quarter results, which will be issued at approximately 7:00 a.m. ET the same day. The webcast will be hosted by Emmanuel Babeau, Chief Financial Officer, and will include a discussion of PMI’s financial results, as well as a Q&A session with the investment community. The webcast will be in a listen-only mode. The audio webcast may also be accessed on mobile devices by downloading PMI’s ...
New Myriad Genetics Study Published in Prenatal Diagnosis Shows High P...
New Myriad Genetics Study Published in Prenatal Diagnosis Shows High Positive Predictive Value for 22q11.2 Microdeletion Syndrome Using Prequel® Prenatal Screen SALT LAKE CITY, April 16, 2024 (GLOBE NEWSWIRE) -- , (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced that Prenatal Diagnosis has published a 1 demonstrating exceptional positive predictive value (PPV) for 22q11.2 microdeletion screening using Myriad’s prenatal cell-free DNA (pcfDNA) screen, Prequel®, which incorporates fetal fraction amplification. Prior studies from other commercial pcfDNA lab...
Myriad Genetics Research Shows Reduction in Hospitalizations for Patie...
Myriad Genetics Research Shows Reduction in Hospitalizations for Patients with Depression after GeneSight Testing Fewer patients were prescribed medications with gene-drug interactions after taking the GeneSight test SALT LAKE CITY, April 09, 2024 (GLOBE NEWSWIRE) -- . (NASDAQ: MYGN), a leader in genetic testing and precision medicine, revealed results from a multi-year, real-world study of nearly 21,000 patients that indicated those with major depressive disorder had reduced healthcare utilization after taking the . “We are encouraged by the initial results of this study that sh...
Philip Morris International Demonstrates Clear Progress Toward Its Pur...
STAMFORD, CT--(BUSINESS WIRE)-- Philip Morris International Inc. (PMI) (NYSE: PM) today releases its fifth annual Integrated Report, which outlines the company’s ongoing work to advance toward its 2025 Roadmap goals, with the primary focus on addressing the health impacts of the company’s products. The 2023 Integrated Report highlights PMI’s continued expansion of smoke-free alternatives in markets worldwide, as well as social and environmental programs deployed with and in parallel to these products—including the deployment of responsible marketing and sales practices and efforts to reduce ...
Philip Morris International Names New External Affairs Leader
STAMFORD, Conn--(BUSINESS WIRE)-- Philip Morris International Inc. (PMI) (NYSE: PM) is pleased to announce the appointment of Christos Harpantidis to the position of Senior Vice President, External Affairs effective May 1, 2024. In his new role, Mr. Harpantidis will report to the company’s CEO, Jacek Olczak. “Christos is an experienced business leader with a proven track record of engaging society on the benefits of tobacco harm reduction and risk-proportionate regulation for smoke-free products,” said CEO Jacek Olczak. “He has been instrumental in building our smoke-free business in Greece ...
Unleashing the Power: How the “Fifth Estate” Drives Decision-Makers in...
STAMFORD, CT--(BUSINESS WIRE)-- Individuals now wield substantial influence over the decision-making process of established institutions. Philip Morris International (PMI) (NYSE: PM) examined this topic in a white paper and an international survey recently released that discusses how individuals are leveraging the power of the “Fifth Estate” to transform public dialogue, influence policymaking, and challenge traditional institutions of authority. By leveraging the positive aspects of this emerging influence, society can drive meaningful action on the world’s critical issues. “The world’s hie...
Myriad Genetics Announces Foundational Patent Granted for Molecular Re...
Myriad Genetics Announces Foundational Patent Granted for Molecular Residual Disease (MRD) with Early Priority Date SALT LAKE CITY, March 21, 2024 (GLOBE NEWSWIRE) -- , (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced that the United States Patent and Trademark Office has issued a patent that will strengthen its ability to deliver a tumor-informed, high-definition, molecular residual disease (MRD) assay to market. U.S. patent 11,932,910, entitled Combinatorial DNA Screening, covers Myriad’s foundational and proprietary method of preparing cell free DNA...
Myriad Genetics Announces Patent Granted for SneakPeek® Snap Device
Myriad Genetics Announces Patent Granted for SneakPeek® Snap Device SALT LAKE CITY, March 20, 2024 (GLOBE NEWSWIRE) -- , (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced that the U.S. Patent and Trademark Office has granted a patent that covers the use of push-button blood collection devices for PCR-based fetal sex determination. U.S. Patent No. 11,932,907, titled Fetal Sex Determination Using Capillary Blood From Upper Arm, provides protection for Myriad’s SneakPeek Snap® products in the U.S through 2040. The patent further covers technology for improv...
Philip Morris International Launches New IQOS ILUMA i in Japan to Acce...
LAUSANNE, Switzerland--(BUSINESS WIRE)-- Philip Morris International Inc. (PMI) (NYSE: PM) today announced the launch of IQOS ILUMA i, the latest and most innovative addition to its growing portfolio of smoke-free products for adults who would otherwise continue to smoke or use nicotine products. Today, this range of better alternatives to cigarettes includes multiple generations of IQOS, the No. 1 tobacco heating system.1 The launch also marks the 10-Year anniversary of IQOS, originally launching in Nagoya, Japan in 2014. “We leverage science, world leading brands and commercial capabilitie...
Philip Morris International Inc. Declares Regular Quarterly Dividend o...
STAMFORD, CT--(BUSINESS WIRE)-- Regulatory News: The Board of Directors of Philip Morris International Inc. (NYSE: PM) today declared a regular quarterly dividend of $1.30 per common share, payable on April 9, 2024, to shareholders of record as of March 21, 2024. The ex-dividend date is March 20, 2024. For more details on stock, dividends and other information, see . Philip Morris International: Delivering a Smoke-Free Future Philip Morris International (PMI) is a leading international tobacco company, actively delivering a smoke-free future and evolving its portfolio for the long term t...
Philip Morris International’s U.S. Business Champions Female Economic ...
STAMFORD, Conn.--(BUSINESS WIRE)-- Today, Philip Morris International (PMI) (NYSE: PM) announces the launch of an extended partnership via its U.S. business to support female empowerment with a record-setting $5 million investment in the Women’s Business Development Council (WBDC), a 501(c)(3) charitable organization dedicated to providing tools and resources to help women entrepreneurs thrive in business throughout Connecticut. This press release features multimedia. View the full release here: (from left to right) Marian Salzman, Senior Vice President & Chief Corporate Citizenship Officer, ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.